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Real-time PCR methodology can successfully quantitate 
microchimeric cell populations at a concentration of 100 
microchimeric cells/100,000 host cells; however, it has not 
been successful in quantitating DNA from trace numbers of 
microchimeric white blood cells which we reported are present 
in murine peripheral blood at a concentration as low as 
2/100,000 host cells. We report methodology using primers for 
a portion of the H2-kb murine histocompatibility sequence, 
specific for the C57BL/6J mouse. When these primers were 
used in the presence of 11,000 µM primer, a 20-fold increase in 
the median manufacturer’s recommended concentration, the 
assay could be optimized to detect 34 pg of C57BL/6J DNA in 
a background of 2.5 µg of carrier BALB/cJ DNA (1/100,000). 
These conditions resulted in a detection limit half as sensitive 




Microchimeric cells are cells found in the blood circulation of 
one individual (the mother) but derived from another 
individual (the fetus) (1). Some of these cells, T-lymphocytes, 
are long lived and have been identified in a mother’s 
circulation 40 years after her last pregnancy (2). Real-time 
PCR has been successfully employed to detect the presence of 
microchimeric fetal cell DNA for prenatal diagnosis in plasma 
and serum (3, 4). The technique has been used to identify 
fetuses having the following diseases: Downs syndrome (5) 
and RhD status (6). However, the detection of trace numbers of 
microchimeric cell DNA from whole peripheral blood 
mononuclear cell DNA has been confounded by the fact that 
the sensitivity of the real-time PCR assay decreases if the 
starting concentration of DNA in the reaction is very high (7). 
Ordinarily, if there were not enough DNA from the 
microchimeric cells in a given sample, then the amount of 
sample to be assayed would be increased to a level that was 
high enough to bring the total number of copies of 
microchimeric DNA to a minimum threshold level which 
could be amplified and detected by real-time PCR. However, 
from our own observations, it is clear that the real-time PCR 
amplification loses sensitivity when the total amount of DNA 
in the assay tube is increased. Byrne et al. (7) reported a real-
time PCR technique that detected chimeric cells in the 
peripheral blood from transplanted mice. Their technique 
employed the zfy2 gene in the murine genome, which 
contained four copies of the target template per male cell. They 
reported an excellent limit of sensitivity for their assay of 6 
copies of target DNA in 40 ng of background DNA. If we 
accept the published value of 6⅔ picograms (pg) of DNA per 
cell (8), then Byrne et al. (7) were able to detect 6 copies of 
male DNA in a background of DNA from 6000 cells.  
 
Unfortunately, the detection of fetal microchimeric cells in 
post-partum murine blood samples requires even more 
sensitivity than that published by Byrne et al. (7). In the 
microchimeric retired breeder mice, which were investigated in 
our laboratory, we found that the microchimeric cells were 
present in concentrations of 0.00002 to 0.005% of the total 
white cell population (9). Most of this range is significantly less 
than one copy of microchimeric DNA in 40 ng of background 
DNA. Therefore, it was necessary to modify the manufacturer’s 
recommended assay conditions and develop a method to 
reliably assay samples containing as much as 2.5 µg of DNA. 
Here we describe a real-time PCR assay that is sensitive 
enough to quantitate the number of fetal microchimeric cells in 
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a background of maternal DNA purified from post-partum 
mouse peripheral blood mononuclear cells. 
 




Virgin female BALB/cJ mice, aged 2 months and female 
BALB/cJ retired breeders (bred to male C57BL/6J or BALB/cJ 
mice) and aged 7-8 months were purchased from The Jackson 
Laboratory (Bar Harbor, ME). These animals had been bred 
multiple times to C57BL/6J males and had delivered a 
minimum of 4 litters before being retired. Animals were 
housed at the Thomas Jefferson University animal facility, 
which is approved by the American Association for 
Accreditation of Laboratory Animal Care (AAALAC). All 
protocols were reviewed and approved by the Thomas 




Blood was obtained by intraocular bleeding into a tube 
containing 0.1M EDTA, pH 8.0, to prevent clotting. DNA was 
extracted according to the following method. The red cells 
were lysed in 1.3 ml 0.144M NH4Cl/100mM NaHCO3. The 
tubes were centrifuged at 3000 rpm and the supernatant 
removed. The white cells were washed two to three times in 
0.144M NH4Cl/100mM NaHCO3 or until the supernatant was 
no longer red. The remaining cells were then centrifuged and 
the supernatant removed. White cells were resuspended in 300 
µl 0.01M Tris (pH 8.0)/0.4M NaCl/0.002M EDTA (pH 8.0) 
and 20 µl 10% SDS and incubated at room temperature with 
shaking until all the cells had lysed. The released DNA was 
purified by precipitation with 100 µl saturated NaCl and 300 µl 
chloroform with vigorous shaking and centrifugation. The 
clear aqueous layer was transferred to a tube and the DNA 
precipitated in 2 volumes of ethanol. The DNA was collected 
with a disposable inoculating needle into 100µl 10mM Tris-
HCl (pH 8.0)/1mM EDTA (pH 8.0). The DNA was analyzed 
on a spectrophotometer at 260 nm and adjusted to a final 
concentration of 500ng/µl.  
 
Real-time PCR amplification of microchimeric 
C57BL/6J DNA 
 
Custom primers were obtained from Research Genetics 
(Huntsville, AL) and were designed to specifically amplify a 
sequence of the IgG sequence unique to the C57BL/6J (10) 
genome (forwards primer: 5’-CAAAGTCTCCAAGCCCT-3’; 
reverse primer: 5’-GACTTACCTGCGCATGG-3’). The 
amount of each primer used varied and is stated in the figure 
legends below. A custom Taqman probe was used, specific to 
the same sequence on the C57BL/6J genome, 5’-(FAM)-
TCGAGTAACCCCCAGCCTTCTCTCTGC-TAMRA)-3’ at a 
concentration of 100 µM. All PCR amplifications were 
performed in duplicate and each analysis contained positive 
controls of C57BL/6J DNA and negative controls of BALB/cJ 
DNA. The default real-time PCR assay conditions were 
employed according to the Applied Biosystems 
recommendations for 45 cycles (11). The break through cycle 
(threshold) was automatically set at 10 standard deviations 
above the mean baseline fluorescence at a point where the 
amplification process had reached the exponential phase. A 
standard curve was obtained simultaneously as unknown 
samples were processed. All standard curves had a slope of at 
least -3.4 and an R-coefficient (efficiency) of greater than 0.98. 
The curve was prepared by serial diluting C57BL/6J DNA to 
the following concentrations 0, 34, 102, 309, and 926 pg per 
assay tube. The C57BL/6J DNA was diluted into water or into 
BALB/cJ DNA such that the final concentration of BALB/cJ 
was 2.5 µg per assay tube. The Taqman amplification reactions 
were adjusted to a final volume of 50µl using the TaqMan® 
Universal PCR Master Mix. Each reaction contained 25µl 
Taqman reaction buffer, comprising of 4mM MgCl2, 200 µM 
each dATP, dCTP, and dGTP; 400 µM dTTP; 1.25U 
AmpliTaq Gold; 0.5U AmpErase. Five-microliters of unknown 
DNA (2.5 µg) was added to each reaction tube.   
   
Anti-contamination procedures 
 
Strict precautions against contamination of the DNA and during 
PCR assays were employed. Separate laboratory areas were 
used to extract DNA, set up PCR reactions, carry out the 
amplifications, and analyze the PCR products by gel 
electrophoresis. As a negative control for the amplification of Y 
chromosome, two nulligravid females were used. Aerosol 
resistant pipette tips were used to handle all solutions. No 
evidence of cross contamination of any samples was observed 
using these methods, as we never detected an allele in a blank 
sample. 
 
RESULTS AND DISCUSSION 
 
From previous published work in which we had developed a 
semi-quantitative method for detecting trace amounts of 
murine fetal DNA in maternal peripheral blood DNA (9), it 
was clear that to detect the DNA from the very small 
population of microchimeric cells, it would be necessary to 
improve the sensitivity of the real-time PCR assay so 
successful PCR amplification could occur when assaying a 
sample containing microgram quantities of DNA. Initially, 
serial dilutions of C57BL/6J DNA were made into water at 0, 
34, 102, 309, and 926 pg and analyzed by real-time PCR. 
Following the manufacturer’s recommended protocol (11), the 
assay was optimized for 900 µM of each forward and reverse 
primer and 100 µM of the probe. Using DNA purified from the 
peripheral blood of a C57BL/6J mouse, these conditions 
yielded a reproducible standard curve (Fig. 1A) when the DNA 
samples were diluted in water. Thirty-four picograms of DNA 
was the lowest reliable point on this curve. When the 
C57BL/6J DNA samples were assayed under the same 
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manufacturer’s recommended conditions but in the presence of 
2.5 µg of BALB/cJ carrier DNA, the sensitivity of the real-
time PCR reaction was essentially eliminated (Fig. 1A). Even 
at the highest concentration of C57BL/6J DNA (926 pg) less 
than 5 cell equivalent (34 pg) of product could be detected. In 
Figure 1B the log of the C57BL/6J DNA concentration is 
plotted against the PCR threshold cycle number (cycle at 
which product was first detectable). It can be seen in this figure 
that the presence of 2.5 µg of BALB/cJ DNA depressed the 
PCR reaction by 4.3 to 6 cycles, which represents a depression 
of 20 to 64 fold. 2.5 µg of BALB/cJ DNA was selected 
because using that amount of DNA would allow us to detect 5 
microchimeric cell equivalents in a background of 375,000 
cells, a level compatible with what we have found in murine 
blood (9). The discovery, that 2.5 µg of BALB/cJ DNA 
reduced the sensitivity of the real-time PCR, explained why we 
were unable to detect significant numbers of microchimeric 
cells by real-time PCR in our test samples. 
 
 
Fig. 1: A real-time PCR assay in which a C57BL/6J strain-specific DNA 
sequence was amplified in the presence or absence of 2.5 µg of BALB/cJ 
DNA using the highest recommended manufacturer’s primer 
concentration. The figure plots the cycle number at which fluorescence was 
first detected (breakthrough cycle) against the log of the concentration of the 
C57BL/6J DNA. From this plot it is possible to quantitate the effect of the 
carrier DNA on the sensitivity of the assay, because, if the breakthrough cycle 
number increases by one, the sensitivity decreases by half. The average 
increase in breakthrough cycle number between the curves was 5.5 to 6.5 
cycles indicating a loss of sensitivity of 64 fold. Clearly these conditions were 
inadequate to identify trace amounts of C57Bl6/J DNA in a high background 
of BALB/cJ DNA. 
 
Although we did not completely understand why the large 
amount of BALB/cJ DNA should lead to such a dramatic 
decrease in the sensitivity of the real-time PCR for the trace 
amounts of the C57BL/6J DNA sequence, we hypothesized 
that the decrease in sensitivity might be due to non-specific 
binding of the primers to the BALB/cJ DNA and therefore 
these reagents would not be available to bind to the correct 
C57BL/6J DNA sequence. To test this hypothesis, we 
performed real-time PCR reactions at 11,000 µM 
approximately 12 times the manufacturer’s highest 
recommended concentration of each primer. The results of 
these assays are shown in Figure 2. It can be seen that there 
was a reversal of the loss of sensitivity when 11,000 µM of 
each primer was used, compared to 900 µM of each primer. At 
11,000 µM primer concentration, the cycle number at which 
PRC product could first be detected was delayed by 1 cycle 
representing a depression of sensitivity of 50 percent compared 
to the value obtained when the C57BL/6J DNA was assayed 
without carrier BALB/cJ DNA. To determine if the 11,000 µM 
concentration of each primer was the optimal concentration for 
assaying 2.5 µg of DNA, the real-time PCR reaction was 
performed at 900, 2200, 5500, 11,000, 16,500 and 22,000 µM 
primer concentration. The results are shown in Figure 3. It can 
be seen that the sensitivity of this assay increases with primer 
concentration until it reached a maximum at or around 11,000 
µM of primer and then falls off above that point. Although 
11,000 µM of primer was the optimal concentration of primer, 
of the concentrations tested, it appears that any concentration 




Fig. 2: Real-time PCR showing the breakthrough cycle number for 
amplification of a C57BL/6J strain specific DNA sequence. The PCR was 
performed with the amounts of primer and carrier BALB/cJ DNA as shown. 
The figure indicates that in the presence of 11,000 uM primer the breakthrough 
cycle number is decreased by 3.5 to 5.5 cycles in the presence of 2.5 ug of 
carrier DNA. By comparing the two lower graph lines, it can be seen that the 
presence of carrier DNA at 11,000 uM carrier concentration only causes the 
breakthrough Cycle number to increase by approximately 1 cycle, indicating 
that in the presence of 11,000 uM carrier the sensitivity of the assay is only 
decreased by half instead of 64 fold when using the manufacturer’s 
recommended concentration for primers. 
 
 
Fig. 3: Real-time PCR showing the breakthrough cycle number for 
amplification of a C57BL/6J strain specific DNA sequence. The PCR was 
performed with primer amounts varying from 900 to 22,000 µM in the presence 
of 2.5 µg of BALB/cJ DNA unless otherwise noted. This figure shows that the 
optimal primer concentration for detection of C57BL6/J DNA in the presence 
of 2.5 ug of BALB/cJ carrier DNA is 11,000 uM (----- line), because this line 
has the lowest breakthrough cycle number except for the control performed 
with no carrier DNA (------ in H2O). However, it should be noted that given an 
error range of 5-10% for these assays that primer concentrations between 2200 
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and 11,000 uM are equally affective in optimizing the assay for detection of 
trace mircochimeric C57BL/6J DNA in 2.5 ug of BALB/cJ DNA.   
 
Experiments to optimize the probe concentration were not 
carried out, because the probe is much more costly than the 
primers and the probe would be expected to bind more 
specifically than the primers because it is 27 bp in length and 
the primers are only 17 bp. However, we did perform one 
experiment in which the probe concentration was increased 5 
fold to 500 µM. There was no dose response correlation 
between the amount of C57BL/6J DNA added to the assay 
tube and the fluorometric response observed with the Taqman 
real-time PCR machine at 500 µM (data not shown) and the 
effect of changing the probe concentration from that 
recommended by the manufacturer (11) was not investigated 
further.  
 
Although the real-time PCR analysis has been used previously 
for the detection of nucleic acids in a limited quantity of 
starting material, the detection of trace DNA sequences in 
large quantities of carrier genomic DNA has been confounded 
by the problems elucidated above. These results suggest that 
the limitations in the sensitivity of the real-time PCR assay 
caused by large amounts of carrier DNA can be overcome by 
using forward and reverse primers at concentrations higher 
than that recommended by the manufacturer. Under these 
conditions, the assay was sensitive enough to detect 34 pg of 
DNA (5 cell equivalents) in 2.5 µg of maternal DNA. We have 
found this method to be approximately 50 times more sensitive 
than the method reported by Byrne et al. (7) who reported 
detecting 6 cell equivalents in up to 40 ng of DNA.  
 
The decrease in sensitivity to 50% of the values found, when no 
carrier DNA was present, was acceptable for our purposes of 
detecting microchimeric DNA in murine peripheral blood. We 
were able to detect the presence of 5 microchimeric cells in a 
background of 375,000 host cells which is approximately 1 cell 
equivalent in 75,000 cells. In addition, the conditions for an 
optimal real-time PCR amplification in the presence of 
microgram quantities of DNA are most likely, in part, 
dependent on the particular set of primers and the probe 
selected. Therefore, optimization assays should be performed 
with each set of reagents to determine the proper concentrations 
for each. 
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